Mulmit

Marker Therapeutics, Inc.Marker Therapeutics, Inc.

MRKR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-313,546,669-12,890,426-12,163,620-0.79
2024-12-316,591,080-11,118,372-10,731,315-1.19
2023-12-313,311,133-14,581,378-8,236,814-0.94
2022-12-313,513,544-19,791,004-29,930,694-3.58
2021-12-311,241,710-39,477,995-41,878,871-5.47

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-11-17Knobil Katharine84,411
2025-11-17Knobil Katharine137,330
2025-11-17Eansor Norman David84,411
2025-11-17Eansor Norman David137,330
2025-11-17ELMS STEVE84,411
2025-11-17ELMS STEVE137,330
2025-10-31Corzo Kathryn Penkus147,611
2025-10-31Vera JuanChief Executive Officer250,000
2025-02-12ELMS STEVE30,000
2025-02-12Knobil Katharine30,000
2025-02-12Eansor Norman David30,000
2025-02-12Vera JuanPresident and CEO50,000

8-K events

FiledItems
2026-05-04Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-03-19Results of operations · Financial statements and exhibits
2026-02-09Shareholder director nominations · Financial statements and exhibits
2025-11-14Results of operations · Financial statements and exhibits
2025-11-05Officer or director change · Other events · Financial statements and exhibits
2025-10-06Other events · Financial statements and exhibits
2025-08-26Regulation FD disclosure · Financial statements and exhibits
2025-08-12Change in certifying accountant · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.